Matthew B. Young, B.S. - Publications

Psychology Emory University, Atlanta, GA 
Behavioral Pharmacology (MDMA)

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.


Year Citation  Score
2018 Young MB, Howell LL, Hopkins L, Moshfegh C, Yu Z, Clubb L, Seidenberg J, Park J, Swiercz AP, Marvar PJ. A peripheral immune response to remembering trauma contributes to the maintenance of fear memory in mice. Psychoneuroendocrinology. 94: 143-151. PMID 29783162 DOI: 10.1016/j.psyneuen.2018.05.012  0.76
2017 Pitts EG, Curry DW, Hampshire KN, Young MB, Howell LL. (±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA. Psychopharmacology. PMID 29248945 DOI: 10.1007/s00213-017-4812-5  0.76
2017 Curry DW, Young MB, Tran AN, Daoud GE, Howell LL. Separating the agony from ecstasy: R(-)-3,4 methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice. Neuropharmacology. PMID 28993129 DOI: 10.1016/j.neuropharm.2017.10.003  0.76
2017 Young MB, Norrholm SD, Khoury LM, Jovanovic T, Rauch SAM, Reiff CM, Dunlop BW, Rothbaum BO, Howell LL. Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA). Psychopharmacology. PMID 28741031 DOI: 10.1007/s00213-017-4684-8  0.76
2015 Young MB, Andero R, Ressler KJ, Howell LL. 3,4-Methylenedioxymethamphetamine facilitates fear extinction learning. Translational Psychiatry. 5: e634. PMID 26371762 DOI: 10.1038/tp.2015.138  0.76
2014 Young MB, Thomas SA. M1-muscarinic receptors promote fear memory consolidation via phospholipase C and the M-current. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 1570-8. PMID 24478341 DOI: 10.1523/JNEUROSCI.1040-13.2014  1
2014 Lehman PW, Kendall C, Guerin MA, Young MB, Silva SR, Boyer GL, Teh SJ. Characterization of the Microcystis Bloom and Its Nitrogen Supply in San Francisco Estuary Using Stable Isotopes Estuaries and Coasts. 38: 165-178. DOI: 10.1007/s12237-014-9811-8  0.36
2013 Thomas SA, Ouyang M, Schutsky KB, Young MB, Castelino CB, Zhang L, Lestini MM. Novel Catecholamine Mechanisms in Memory Consolidation and Retrieval During Stress Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 247. DOI: 10.1016/B978-0-12-800044-1.00217-8  1
2012 Ouyang M, Young MB, Lestini MM, Schutsky K, Thomas SA. Redundant catecholamine signaling consolidates fear memory via phospholipase C. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 1932-41. PMID 22323706 DOI: 10.1523/JNEUROSCI.5231-11.2012  1
2010 Su DS, Lim JJ, Tinney E, Tucker TJ, Saggar S, Sisko JT, Wan BL, Young MB, Anderson KD, Rudd D, Munshi V, Bahnck C, Felock PJ, Lu M, Lai MT, et al. Biaryl ethers as potent allosteric inhibitors of reverse transcriptase and its key mutant viruses: aryl substituted pyrazole as a surrogate for the pyrazolopyridine motif. Bioorganic & Medicinal Chemistry Letters. 20: 4328-32. PMID 20609585 DOI: 10.1016/j.bmcl.2010.06.083  0.36
2010 Rajapakse HA, Nantermet PG, Selnick HG, Barrow JC, McGaughey GB, Munshi S, Lindsley SR, Young MB, Ngo PL, Holloway MK, Lai MT, Espeseth AS, Shi XP, Colussi D, Pietrak B, et al. SAR of tertiary carbinamine derived BACE1 inhibitors: role of aspartate ligand amine pKa in enzyme inhibition. Bioorganic & Medicinal Chemistry Letters. 20: 1885-9. PMID 20176482 DOI: 10.1016/j.bmcl.2010.01.137  0.36
2010 Zhu H, Young MB, Nantermet PG, Graham SL, Colussi D, Lai MT, Pietrak B, Price EA, Sankaranarayanan S, Shi XP, Tugusheva K, Holahan MA, Michener MS, Cook JJ, Simon A, et al. Rapid P1 SAR of brain penetrant tertiary carbinamine derived BACE inhibitors. Bioorganic & Medicinal Chemistry Letters. 20: 1779-82. PMID 20122828 DOI: 10.1016/j.bmcl.2010.01.005  0.36
2010 Carr GV, Bangasser DA, Bethea T, Young M, Valentino RJ, Lucki I. Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 752-63. PMID 19924112 DOI: 10.1038/npp.2009.183  1
2009 Su DS, Lim JJ, Tinney E, Wan BL, Young MB, Anderson KD, Rudd D, Munshi V, Bahnck C, Felock PJ, Lu M, Lai MT, Touch S, Moyer G, DiStefano DJ, et al. Biaryl ethers as novel non-nucleoside reverse transcriptase inhibitors with improved potency against key mutant viruses. Journal of Medicinal Chemistry. 52: 7163-9. PMID 19883100 DOI: 10.1021/jm901230r  0.36
2009 Su DS, Lim JJ, Tinney E, Wan BL, Young MB, Anderson KD, Rudd D, Munshi V, Bahnck C, Felock PJ, Lu M, Lai MT, Touch S, Moyer G, Distefano DJ, et al. Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants. Bioorganic & Medicinal Chemistry Letters. 19: 5119-23. PMID 19631528 DOI: 10.1016/j.bmcl.2009.07.031  0.36
2009 Smith SM, Uslaner JM, Yao L, Mullins CM, Surles NO, Huszar SL, McNaughton CH, Pascarella DM, Kandebo M, Hinchliffe RM, Sparey T, Brandon NJ, Jones B, Venkatraman S, Young MB, et al. The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine. The Journal of Pharmacology and Experimental Therapeutics. 328: 921-30. PMID 19088300 DOI: 10.1124/jpet.108.147884  0.36
2008 Sparey T, Abeywickrema P, Almond S, Brandon N, Byrne N, Campbell A, Hutson PH, Jacobson M, Jones B, Munshi S, Pascarella D, Pike A, Prasad GS, Sachs N, Sakatis M, ... ... Young MB, et al. The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors. Bioorganic & Medicinal Chemistry Letters. 18: 3386-91. PMID 18455394 DOI: 10.1016/j.bmcl.2008.04.020  0.36
2007 Lindsley SR, Moore KP, Rajapakse HA, Selnick HG, Young MB, Zhu H, Munshi S, Kuo L, McGaughey GB, Colussi D, Crouthamel MC, Lai MT, Pietrak B, Price EA, Sankaranarayanan S, et al. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17: 4057-61. PMID 17482814 DOI: 10.1016/j.bmcl.2007.04.072  0.36
2006 Rajapakse HA, Nantermet PG, Selnick HG, Munshi S, McGaughey GB, Lindsley SR, Young MB, Lai MT, Espeseth AS, Shi XP, Colussi D, Pietrak B, Crouthamel MC, Tugusheva K, Huang Q, et al. Discovery of oxadiazoyl tertiary carbinamine inhibitors of beta-secretase (BACE-1). Journal of Medicinal Chemistry. 49: 7270-3. PMID 17149856 DOI: 10.1021/jm061046r  0.36
2006 Rajapakse HA, Zhu H, Young MB, Mott BT. A mild and efficient one pot synthesis of 1,3,4-oxadiazoles from carboxylic acids and acyl hydrazides Tetrahedron Letters. 47: 4827-4830. DOI: 10.1016/j.tetlet.2006.05.051  0.36
2005 Rajapakse HA, Young MB, Zhu H, Charlton S, Tsou NN. Asymmetric synthesis of dihydroquinazolinones via directed ortho metalation and addition to tert-butanesulfinyl imines Tetrahedron Letters. 46: 8909-8912. DOI: 10.1016/j.tetlet.2005.10.067  0.36
2004 Young MB, Barrow JC, Glass KL, Lundell GF, Newton CL, Pellicore JM, Rittle KE, Selnick HG, Stauffer KJ, Vacca JP, Williams PD, Bohn D, Clayton FC, Cook JJ, Krueger JA, et al. Discovery and evaluation of potent P1 aryl heterocycle-based thrombin inhibitors. Journal of Medicinal Chemistry. 47: 2995-3008. PMID 15163182 DOI: 10.1021/jm030303e  0.36
2003 Fraley ME, Arrington KL, Hambaugh SR, Hoffman WF, Cunningham AM, Young MB, Hungate RW, Tebben AJ, Rutledge RZ, Kendall RL, Huckle WR, McFall RC, Coll KE, Thomas KA. Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13: 2973-6. PMID 12941314 DOI: 10.1016/S0960-894X(03)00627-9  0.36
2001 Barrow JC, Nantermet PG, Selnick HG, Glass KL, Ngo PL, Young MB, Pellicore JM, Breslin MJ, Hutchinson JH, Freidinger RM, Condra C, Karczewski J, Bednar RA, Gaul SL, Stern A, et al. Discovery and initial structure-activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists. Bioorganic & Medicinal Chemistry Letters. 11: 2691-6. PMID 11591503 DOI: 10.1016/S0960-894X(01)00538-8  0.36
1996 Coburn CA, Young MB, Hungate RW, Isaacs RCA, Vacca JP, Huff JR. Aromatic P1 replacements for the highly potent HIV-1 protease inhibitor CRIXIVAN® Bioorganic and Medicinal Chemistry Letters. 6: 1937-1940. DOI: 10.1016/0960-894X(96)00345-9  0.36
1993 Lynch JJ, Wallace AA, Van der Gaag LH, Baskin EP, Bear CM, Gehret JR, Kothstein T, Stupienski RF, Appleby SD, Sanguinetti MC, Jurkiewicz NK, Zingaro GJ, Stein RB, Claremon DA, Elliott JM, ... Young MB, et al. Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'- [2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro[(2H)-1-benzopyran- 2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent Journal of Pharmacology and Experimental Therapeutics. 265: 720-730. PMID 8496818  0.36
1993 Evans BE, Lundell GF, Gilbert KF, Bock MG, Rittle KE, Carroll LA, Williams PD, Pawluczyk JM, Leighton JL, Young MB. Nanomolar-affinity, non-peptide oxytocin receptor antagonists. Journal of Medicinal Chemistry. 36: 3993-4005. PMID 8258821  0.36
1992 Elliott JM, Selnick HG, Claremon DA, Baldwin JJ, Buhrow SA, Butcher JW, Habecker CN, King SW, Lynch JJ, Phillips BT, Ponticello GS, Radzilowski EM, Remy DC, Stein RB, White JI, ... Young MB, et al. 4-Oxospiro[benzopyran-2,4′-piperidines] as class III antiarrhythmic agents. Pharmacological studies on 3,4-dihydro-1′-[2-(benzofurazan-5-yl)-ethyl]-6- methanesulfonamidospiro[(2H)-1-benzopyran-2,4′-piperidin]-4-one (L-691,121) Journal of Medicinal Chemistry. 35: 3973-3976. PMID 1433205  0.36
Show low-probability matches.